Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers.

[1]  G. Hutchins,et al.  An Improved Total Synthesis of PET HSV‐tk Gene Expression Imaging Agent 9‐[(3‐[18F]Fluoro‐1‐hydroxy‐2‐propoxy)methyl]guanine ([18F]FHPG) , 2004 .

[2]  G. Hutchins,et al.  An Improved Total Synthesis of PET HSV‐tk Gene Reporter Probe 9‐(4‐[18F]Fluoro‐3‐hydroxymethylbutyl)guanine ([18F]FHBG) , 2004 .

[3]  G. Hutchins,et al.  Novel radiosynthesis of PET HSV-tk gene reporter probes [18F]FHPG and [18F]FHBG employing dual Sep-Pak SPE techniques. , 2003, Bioorganic & medicinal chemistry letters.

[4]  G. Hutchins,et al.  Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester. , 2003, Nuclear medicine and biology.

[5]  Y. Fujibayashi,et al.  Trends in nucleoside tracers for PET imaging of cell proliferation. , 2003, Nuclear medicine and biology.

[6]  D. Miles,et al.  XELODA® AND TAXOTERE®: A REVIEW OF THE DEVELOPMENT OF THE COMBINATION FOR USE IN METASTATIC BREAST CANCER , 2003, International journal of clinical practice.

[7]  P. Hoff.  Practical considerations in the use of oral fluoropyrimidines. , 2003, Seminars in oncology.

[8]  G. Hutchins,et al.  Facile synthesis of [11C]edrophonium and its analogues as new potential PET imaging agents for heart acetylcholinesterase. , 2003, Bioorganic & medicinal chemistry letters.

[9]  G. Hutchins,et al.  Synthesis and preliminary biological evaluation of radiolabeled O6-benzylguanine derivatives, new potential PET imaging agents for the DNA repair protein O6-alkylguanine-DNA alkyltransferase in breast cancer. , 2003, Nuclear medicine and biology.

[10]  G. Hutchins,et al.  Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential pet tumor imaging agent , 2003 .

[11]  H. Ishitsuka,et al.  Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine. , 2003, Bioorganic & medicinal chemistry letters.

[12]  Dae Hyuk Moon,et al.  High radiochemical yield synthesis of 3'-deoxy-3'-[18F]fluorothymidine using (5'-O-dimethoxytrityl-2'-deoxy-3'-O-nosyl-beta-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor. , 2003, Nuclear medicine and biology.

[13]  W. Scheithauer,et al.  Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies , 2003, Anti-cancer drugs.

[14]  G. Hutchins,et al.  [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice. , 2002, Nuclear medicine and biology.

[15]  C. Twelves,et al.  The rational development of capecitabine from the laboratory to the clinic. , 2002, Anticancer research.

[16]  G. Hutchins,et al.  Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents. , 2002, Nuclear medicine and biology.

[17]  H. Katabuchi,et al.  Thymidine kinase in epithelial ovarian cancer: Relationship with the other pyrimidine pathway enzymes , 2002, International journal of cancer.

[18]  J. Kuhn.  Fluorouracil and the New Oral Fluorinated Pyrimidines , 2001, The Annals of pharmacotherapy.

[19]  K. Goa,et al.  Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer. , 2001, Drugs.

[20]  H. Ishitsuka,et al.  The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine. , 2000, Bioorganic & medicinal chemistry.

[21]  Q. Zheng,et al.  Isomerization Study of Aryltropane Analogs of Cocaine , 2000 .

[22]  D. Frye,et al.  Capecitabine: nursing implications of a new oral chemotherapeutic agent. , 1999, Oncology nursing forum.

[23]  B. Mock,et al.  Convenient labeling and isolation of [11C-methyl]quaternary amines , 1999 .

[24]  B. Mock,et al.  A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations. , 1997, Nuclear medicine and biology.

[25]  W. Arnold,et al.  Stereospezifische Synthese des Cancerostatikums 5′‐Desoxy‐5‐fluor‐uridin (5‐DFUR) und seiner 5′ ‐deuterierten Derivate , 1982 .